Ischemic Stroke and Sleep: The Linking Genetic Factors

Lyudmila Korostovtseva, Lyudmila Korostovtseva

Abstract

This review summarizes the available data about genetic factors which can link ischemic stroke and sleep. Sleep patterns (subjective and objective measures) are characterized by heritability and comprise up to 38-46%. According to Mendelian randomization analysis, genetic liability for short sleep duration and frequent insomnia symptoms is associated with ischemic stroke (predominantly of large artery subtype). The potential genetic links include variants of circadian genes, genes encoding components of neurotransmitter systems, common cardiovascular risk factors, as well as specific genetic factors related to certain sleep disorders.

Keywords: Cardiovascular prevention; Cardiovascular risk; Cerebrovascular disease; Circadian rhythms; Clock genes; Genetics; Ischemia–reperfusion; Ischemic stroke; Sleep; Sleep disorders.

© 2021. The Author(s).

References

    1. Durmaz AA, Karaca E, Demkow U, Toruner G, Schoumans J, Cogulu O. Evolution of genetic techniques: past, present, and beyond. BioMed Res Int. 2015 doi: 10.1155/2015/461524.
    1. Erhart G, Lamina C, Lehtimäki T, et al. Genetic factors explain a major fraction of the 50% lower lipoprotein(a) concentrations in Finns. Arterioscler Thromb Vasc Biol. 2018;38(5):1230–1241. doi: 10.1161/ATVBAHA.118.310865.
    1. NINDS Stroke Genetics Network (SiGN) and International Stroke Genetics Consortium Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Global Health. 2015;4422(15):4–7. doi: 10.1016/S1474-4422(15)00338-5.
    1. Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11(11):951–962. doi: 10.1016/S1474-4422(12)70234-X.
    1. Pulit SL, McArdle PF, Wong Q, et al. The NINDS Stroke Genetics Network: a genome-wide association study of ischemic stroke and its subtypes. Lancet Neurol. 2016;15(2):174–184. doi: 10.1016/S1474-4422(15)00338-5.The.
    1. Cai H, Liang J, Liu Z, et al. Causal effects of sleep traits on ischemic stroke and its subtypes: a Mendelian randomization study. Nat Sci Sleep. 2020;12:783–790. doi: 10.2147/NSS.S265946.
    1. Lu H, Wu PF, Li RZ, Zhang W, Huang GX. Sleep duration and stroke: a Mendelian randomization study. Front Neurol. 2020;11(October):1–6. doi: 10.3389/fneur.2020.00976.
    1. Duan R, Liu X, Wang T, Wu L, Gao X, Zhang Z. Histone acetylation regulation in sleep deprivation-induced spatial memory impairment. Neurochem Res. 2016;41(9):2223–2232. doi: 10.1007/s11064-016-1937-6.
    1. Zheng Q, Ma Y, Chen S, Che Q, Zhou Z, Chen D. Identification of genetic loci jointly influencing coronary artery disease risk and sleep traits of insomnia, sleep duration, and chronotype. Sleep Med. 2020;74:116–123. doi: 10.1016/j.sleep.2020.06.027.
    1. Foo JC, Trautmann N, Sticht C, et al. Longitudinal transcriptome-wide gene expression analysis of sleep deprivation treatment shows involvement of circadian genes and immune pathways. Transl Psychiatry. 2019 doi: 10.1038/s41398-019-0671-7.
    1. Sandford AJ, Ha A, Ngan DA, et al. Adhesion molecule gene variants and plasma protein levels in patients with suspected obstructive sleep apnea. PLoS ONE. 2019;14(1):1–12. doi: 10.1371/journal.pone.0210732.
    1. Zhao W, Yuan T, Fu Y, et al. Seasonal differences in the transcriptome profile of the Zhedong white goose (Anser cygnoides) pituitary gland. Poult Sci. 2021;100(2):1154–1166. doi: 10.1016/j.psj.2020.10.049.
    1. Reis LM, Tyler RC, Volkmann Kloss BA, et al. PITX2 and FOXC1 spectrum of mutations in ocular syndromes. Eur J Hum Genet. 2012;20(12):1224–1233. doi: 10.1038/ejhg.2012.80.
    1. Milićević N, Duursma A, ten Asbroek ALMA, Felder-Schmittbuhl MP, Bergen AA. Does the circadian clock make RPE-mediated ion transport “tick” via SLC12A2 (NKCC1)? Chronobiol Int. 2019;36(11):1592–1598. doi: 10.1080/07420528.2019.1653317.
    1. Chauhan G, Arnold CR, Chu AY, et al. Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2016;15(7):695–707. doi: 10.1016/S1474-4422(16)00102-2.
    1. Lane JM, Liang J, Vlasac I, et al. Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat Genet. 2017;49(2):274–281. doi: 10.1038/ng.3749.
    1. Traylor M, Andreson C, Rutten-Jacobs LCA, et al. The subtype specificity of genetic loci associated with stroke in 16,664 cases and 32,792 controls. Circ Genom Precis Med. 2019;12(7):e002338. doi: 10.1161/CIRCGEN.118.002338.The.
    1. Buck D, Diefenbach K, Penzel T, Malzahn U, Roots I, Fietze I. Genetic polymorphisms in endothelin-receptor-subtype-a-gene as susceptibility factor for obstructive sleep apnea syndrome. Sleep Med. 2010;11(2):213–217. doi: 10.1016/j.sleep.2009.06.009.
    1. Chatsuriyawong S, Gozal D, Kheirandish-Gozal L, et al. Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea. BMC Med Genom. 2013;6(1):1. doi: 10.1186/1755-8794-6-29.
    1. Krohn M, Bracke A, Avchalumov Y, et al. Accumulation of murine amyloid-β mimics early Alzheimer’s disease. Brain. 2015;138(8):2370–2382. doi: 10.1093/brain/awv137.
    1. Nishiyama T, Nakatochi M, Goto A, et al. Genome-wide association meta-analysis and Mendelian randomization analysis confirm the influence of ALDH2 on sleep duration in the Japanese population. Sleep. 2019;42(6):1–11. doi: 10.1093/sleep/zsz046.
    1. Lin CY, Yu RL, Wu RM, Tan CH. Effect of ALDH2 on sleep disturbances in patients with Parkinson’s disease. Sci Rep. 2019;9(1):1–8. doi: 10.1038/s41598-019-55427-w.
    1. Lahtinen A, Puttonen S, Vanttola P, et al. A distinctive DNA methylation pattern in insufficient sleep. Sci Rep. 2019;9(1):1–9. doi: 10.1038/s41598-018-38009-0.
    1. Fu X-J, Li H-X, Yang K, Chen D, Tang H. The important tumor suppressor role of PER1 in regulating the cyclin–cDK–cKi network in scc15 human oral squamous cell carcinoma cells. Oncol Targets Ther. 2016;9:2237–2245.
    1. Bouchard-Cannon P, Mendoza-Viveros L, Yuen A, Kærn M, Cheng HYM. The circadian molecular clock regulates adult hippocampal neurogenesis by controlling the timing of cell-cycle entry and exit. Cell Rep. 2013;5(4):961–973. doi: 10.1016/j.celrep.2013.10.037.
    1. Fan M, Sun D, Zhou T, et al. Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385,292 UK biobank participants. Eur Heart J. 2020;41(11):1182–1189. doi: 10.1093/eurheartj/ehz849.
    1. Krittanawong C, Tunhasiriwet A, Wang Z, et al. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2019;8(8):762–770. doi: 10.1177/2048872617741733.
    1. Cai H, Shu XO, Xiang YB, et al. Sleep duration and mortality: a prospective study of 113,138 middle-aged and elderly Chinese men and women. Sleep. 2015;38(4):529–536. doi: 10.5665/sleep.4564.
    1. Jin X, Pan B, Dang X, Wu H, Xu D. Relationship between short telomere length and stroke: a meta-analysis. Medicine (Baltimore) 2018;97(39):e12489. doi: 10.1097/MD.0000000000012489.
    1. James S, McLanahan S, Brooks-Gunn J, et al. Sleep duration and telomere length in children. J Pediatr. 2017;187:247–252. doi: 10.1016/j.jpeds.2017.05.014.Sleep.
    1. Heath AC, Kendler KS, Eaves LJ, Martin NG. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep. 1990;13(4):318–335. doi: 10.1093/sleep/13.4.318.
    1. Jones SE, van Hees VT, Mazzotti DR, et al. Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour. Nat Commun. 2019;10(1):1–12. doi: 10.1038/s41467-019-09576-1.
    1. Morselli LL, Gamazon ER, Tasali E, Cox NJ, Van Cauter E, Davis LK. Shared genetic control of brain activity during sleep and insulin secretion: a laboratory-based family study. Diabetes. 2018;67(1):155–164. doi: 10.2337/db16-1229.
    1. Dashti HS, Jones SE, Wood AR, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10(1):1–12. doi: 10.1038/s41467-019-08917-4.
    1. Nesbitt AL, Lim ZLT, Chan KJ, Zardawi I, Pridgeon SW. Metastatic renal cell carcinoma presenting with both acute stroke and an oral lesion. Urol Case Rep. 2018;2019(23):75–77. doi: 10.1016/j.eucr.2019.01.010.
    1. Prayson RA. Metastatic chromophobe renal cell carcinoma to the brain. J Clin Neurosci. 2016;26:152–153. doi: 10.1016/j.jocn.2015.10.007.
    1. Jang AI, Bernstock JD, Segar DJ, Distasio M, Matulonis U, Bi WL. Case report: frontoparietal metastasis from a primary fallopian tube carcinoma. Front Surg. 2021;8(February):1–6. doi: 10.3389/fsurg.2021.594570.
    1. Manfredini R, Boari B, Smolensky M, et al. Circadian variation in stroke onset: identical temporal pattern in ischemic and hemorrhagic events. Chronobiol Int. 2005;22(3):417–453. doi: 10.1081/CBI-200062927.
    1. Lincoln GA, Clarke IJ, Hut RAHD. Characterizing a mammalian circannual pacemaker. Science. 2006;314:1941–1944. doi: 10.1126/science.1132009.
    1. Christou S, Wehrens SMT, Isherwood C, et al. Circadian regulation in human white adipose tissue revealed by transcriptome and metabolic network analysis. Sci Rep. 2019;9(1):1–12. doi: 10.1038/s41598-019-39668-3.
    1. Takeda N, Maemura K. The role of clock genes and circadian rhythm in the development of cardiovascular diseases. Cell Mol Life Sci. 2015 doi: 10.1007/s00018-015-1923-1.
    1. Iii EM, Adams HP, Marler JR, Hulbert JR, Love BB, Gordon DL. Circadian variation in onset of acute ischemic stroke. Arch Neurol. 1990;47:1178–1180. doi: 10.1001/archneur.1990.00530110032012.
    1. Zhuang Z, Gao M, Yang R, et al. Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a Mendelian randomization analysis. Lipids Health Dis. 2020;19(1):1–11. doi: 10.1186/s12944-020-01257-z.
    1. Hughes ME, Abruzzi KC, Allada R, et al. Guidelines for genome-scale analysis of biological rhythms. J Biol Rhythms. 2017;32(5):380–393. doi: 10.1177/0748730417728663.
    1. Riestra P, Gebreab SY, Xu R, et al. Circadian CLOCK gene polymorphisms in relation to sleep patterns and obesity in African Americans: findings from the Jackson heart study. BMC Genet. 2017;18(1):1–10. doi: 10.1186/s12863-017-0522-6.
    1. Corella D, Asensio EM, Coltell O, et al. CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial. Cardiovasc Diabetol. 2016;15(1):1–12. doi: 10.1186/s12933-015-0327-8.
    1. Jones SE, Lane JM, Wood AR, et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat Commun. 2019 doi: 10.1038/s41467-018-08259-7.
    1. Veatch OJ, Keenan BT, Gehrman PR, Malow BA, Pack AI. Pleiotropic genetic effects influencing sleep and neurological disorders. Lancet Neurol. 2017;16(2):158–170. doi: 10.1016/S1474-4422(16)30339-8.
    1. Beker MC, Caglayan B, Yalcin E, et al. Time-of-day-dependent neuronal injury after ischemic stroke: implication of circadian clock transcriptional factor bmal1 and survival kinase AKT. Mol Neurobiol. 2018;55(3):2565–2576. doi: 10.1007/s12035-017-0524-4.
    1. Schallner N, Lieberum J-L, Gallo D, et al. Carbon monoxide preserves circadian rhythm to reduce the severity of subarachnoid hemorrhage in mice. Stroke. 2017;48(9):2565–2573. doi: 10.1161/STROKEAHA.116.016165.Carbon.
    1. Lembach A, Stahr A, Ali AAH, Ingenwerth M, von Gall C. Sex-dependent effects of bmal1-deficiency on mouse cerebral cortex infarction in response to photothrombotic stroke. Int J Mol Sci. 2018;19(10):1–16. doi: 10.3390/ijms19103124.
    1. Boden MJ, Varcoe TJ, Voultsios A, Kennaway DJ. Reproductive biology of female Bmal1 null mice. Reproduction. 2010;139(6):1077–1090. doi: 10.1530/REP-09-0523.
    1. Tischkau SA, Cohen JA, Stark JT, Gross DR, Bottum KM. Time-of-day affects expression of hippocampal markers for ischemic damage induced by global ischemia. Exp Neurol. 2007;208(2):314–322. doi: 10.1016/j.expneurol.2007.09.003.
    1. Correa-Costa M, Gallo D, Csizmadia E, et al. Carbon monoxide protects the kidney through the central circadian clock and CD39. Proc Natl Acad Sci USA. 2018;115(10):E2302–E2310. doi: 10.1073/pnas.1716747115.
    1. Cain SW, Chang A, Vlasac I, et al. Circadian rhythms in plasma brain-derived neurotrophic factor differ in men and women. J Biol Rhythms. 2017;32(1):75–82. doi: 10.1177/0748730417693124.
    1. Liang F, Walline R, Earnest DJ. Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci Lett. 1998;242:89–92. doi: 10.1016/S0304-3940(98)00062-7.
    1. Girardet C, Lebrun B, Cabirol-Pol M-J, et al. Brain-derived neurotrophic factor/TrkB signaling regulates daily astroglial plasticity in the suprachiasmatic nucleus: electron-microscopic evidence in mouse. Glia. 2013;61:1172–1177. doi: 10.1002/glia.22509.
    1. Xie H, Yung WH. Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factor. Acta Pharmacol Sin. 2012;33(1):5–10. doi: 10.1038/aps.2011.184.
    1. Flores KR, Viccaro F, Aquilini M, et al. Protective role of brain derived neurotrophic factor (BDNF) in obstructive sleep apnea syndrome (OSAS) patients. PLoS ONE. 2020;15(1):1–11. doi: 10.1371/journal.pone.0227834.
    1. Schmitt K, Holsboer-Trachsler E, Eckert A. BDNF in sleep, insomnia, and sleep deprivation. Ann Med. 2016;48(1–2):42–51. doi: 10.3109/07853890.2015.1131327.
    1. Duez H, Staels B. The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolism. Diab Vasc Dis Res. 2008;5(2):82–88. doi: 10.3132/dvdr.2008.0014.
    1. Sengupta S, Yang G, Donnell JCO, et al. The circadian gene Rev-erbα improves cellular bioenergetics and provides preconditioning for protection against oxidative stress. Free Radic Biol Med. 2016;93:177–189. doi: 10.1016/j.freeradbiomed.2016.02.004.The.
    1. Wolff SEC, Wang XL, Jiao H, et al. The effect of Rev-erbα agonist SR9011 on the immune response and cell metabolism of microglia. Front Immunol. 2020 doi: 10.3389/fimmu.2020.550145.
    1. Zang M, Zhao Y, Gao L, et al. The circadian nuclear receptor RORα negatively regulates cerebral ischemia-reperfusion injury and mediates the neuroprotective effects of melatonin. BBA Mol Basis Dis. 2020 doi: 10.1016/j.bbadis.2020.165890.
    1. Chern CM, Liao JF, Wang YH, Shen YC. Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice. Free Radical Biol Med. 2012;52(9):1634–1647. doi: 10.1016/j.freeradbiomed.2012.01.030.
    1. Andersson EA, Holst B, Sparsø T, et al. MTNR1B G24E variant associates with BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans. Diabetes. 2010;59(June):1539–1548. doi: 10.2337/db09-1757.
    1. Sparsø T, Andersson E, Bouatia-naji N, et al. G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19605 Europeans. Diabetes. 2009;58(June):1450–1456. doi: 10.2337/db08-1660.T.S.
    1. Wilcox AG, Vizor L, Parsons MJ, Banks G, Nolan PM. Inducible knockout of mouse Zfhx3 emphasizes its key role in setting the pace and amplitude of the adult circadian clock. J Biol Rhythms. 2017;32(5):433–443. doi: 10.1177/0748730417722631.
    1. Balzani E, Lassi G, Maggi S, et al. The Zfhx3-mediated axis regulates sleep and interval timing in mice. Cell Rep. 2016;16(3):615–621. doi: 10.1016/j.celrep.2016.06.017.The.
    1. Lee C, Wallingford JB, Gross JM, Gross J. Cluap1 is essential for ciliogenesis and photoreceptor maintenance in the vertebrate eye. Investig Opthalmol Vis Sci. 2014;55(7):4585. doi: 10.1167/iovs.14-14888.
    1. Zhong X, Li JQ, Sun L, et al. A Genome-wide association study of α-synuclein levels in cerebrospinal fluid. Neurotox Res. 2019;35(1):41–48. doi: 10.1007/s12640-018-9922-2.
    1. Falup-Pecurariu C, Diaconu S, Tînt D, Falup-Pecurariu O. Neurobiology of sleep (review) Exp Ther Med. 2021;21(3):1–4. doi: 10.3892/etm.2021.9703.
    1. Ito M, Aswendt M, Lee AG, Ishizaka S, Cao Z, Wang EH, et al. RNA sequencing analysis revealed a distinct motor cortex transcriptome in spontaneously-recovered mice after stroke Masaki. Stroke. 2018;49(9):2191–2199. doi: 10.1161/STROKEAHA.118.021508.RNA.
    1. Qiu J, Yan Z, Tao K, et al. Sinomenine activates astrocytic dopamine D2 receptors and alleviates neuroinflammatory injury via the CRYAB/STAT3 pathway after ischemic stroke in mice. J Neuroinflammation. 2016;13(1):1–13. doi: 10.1186/s12974-016-0739-8.
    1. Hood S, Cassidy P, Cossette MP, et al. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci. 2010;30(42):14046–14058. doi: 10.1523/JNEUROSCI.2128-10.2010.
    1. Cade BE, Gottlieb DJ, Lauderdale DS, et al. Common variants in DRD2 are associated with sleep duration: the CARe Consortium. Hum Mol Genet. 2015;25(1):167–179. doi: 10.1093/hmg/ddv434.
    1. Rhodes JA, Lane JM, Vlasac IM, Rutter MK, Czeisler CA, Saxena R. Association of DAT1 genetic variants with habitual sleep duration in the UK Biobank. Sleep. 2019;42(1):1–6. doi: 10.1093/sleep/zsy193.
    1. Valomon A, Holst SC, Bachmann V, et al. Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults. Chronobiol Int. 2014;31(5):705–714. doi: 10.3109/07420528.2014.896376.
    1. Holst SC, Müller T, Valomon A, Seebauer B, Berger W, Landolt HP. Functional Polymorphisms in dopaminergic genes modulate neurobehavioral and neurophysiological consequences of sleep deprivation. Sci Rep. 2017;7(April):1–11. doi: 10.1038/srep45982.
    1. Holst SC, Bersagliere A, Bachmann V, Berger W, Achermann P, Landolt HP. Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J Neurosci. 2014;34(2):566–573. doi: 10.1523/JNEUROSCI.4128-13.2014.
    1. Jiang Y, Liu B, Wu C, et al. Dopamine receptor d2 gene (Drd2) polymorphisms, job stress, and their interaction on sleep dysfunction. Int J Environ Res Public Health. 2020;17(21):1–11. doi: 10.3390/ijerph17218174.
    1. Vandenbergh DJ, O’Connor RJ, Grant MD, et al. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol. 2007;12(1):106–116. doi: 10.1111/j.1369-1600.2007.00054.x.
    1. Chan T, Bates J, Lansford J, et al. Impulsivity and genetic variants in DRD2 and ANKK1 moderate longitudinal associations between sleep problems and overweight from ages 5 to 11. Int J Obes (Lond) 2014;38(3):404–410. doi: 10.1038/ijo.2013.123.Impulsivity.
    1. Noble EP, Noble RE, Ritchie T, et al. D2 dopamine receptor gene and obesity. Int J Eat Disord. 1994;15(3):205–217. doi: 10.1002/1098-108X(199404)15:3<205::AID-EAT2260150303>;2-P.
    1. Oporto GH, Bornhardt T, Iturriaga V, Salazar LA. Single nucleotide polymorphisms in genes of dopaminergic pathways are associated with bruxism. Clin Oral Invest. 2018;22(1):331–337. doi: 10.1007/s00784-017-2117-z.
    1. Yi HS, Kim HS, Seo MR. Trial of oral metoclopramide on diurnal bruxism of brain injury. Ann Rehabil Med. 2013;37(6):871–874. doi: 10.5535/arm.2013.37.6.871.
    1. Xu H, Guan J, Yi H, Yin S. A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome. PLoS ONE. 2014;9(1):1–8. doi: 10.1371/journal.pone.0086460.
    1. Oporto GH, Bornhardt T, Iturriaga V, Salazar LA. Genetic polymorphisms in the serotonergic system are associated with circadian manifestations of bruxism. J Oral Rehabil. 2016;43(11):805–812. doi: 10.1111/joor.12436.
    1. Kim JM, Stewart R, Bae KY, et al. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord. 2012;136(3):833–840. doi: 10.1016/j.jad.2011.09.029.
    1. Olesen OF, Bennike B, Dam H, Mellerup E. Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke. J Mol Neurosci. 2006;30(3):323–328. doi: 10.1385/JMN:30:3:323.
    1. Bai X, Kirchhoff F, Scheller A. Oligodendroglial GABAergic signaling: more than inhibition! Neurosci Bull. 2021 doi: 10.1007/s12264-021-00693-w.
    1. Okamura M, Inoue T, Takamatsu Y, Maejima H. Low-level inhibition of GABAergic synapses enhances gene expressions crucial for neuronal plasticity in the hippocampus after ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29(12):105316. doi: 10.1016/j.jstrokecerebrovasdis.2020.105316.
    1. Müller HD, Neder A, Sommer C, Schäbitz WR. Different postischemic protein expression of the GABAA receptor α2 subunit and the plasticity-associated protein MAP1B after treatment with BDNF versus G-CSF in the rat brain. Restor Neurol Neurosci. 2009;27(1):27–39. doi: 10.3233/RNN-2009-0459.
    1. Gao J, Qin Z, Qu X, et al. Endogenous neuroprotective mechanism of ATP2B1 in transcriptional regulation of ischemic preconditioning. Am J Transl Res. 2021;13(3):1170–1183.
    1. Wang H, Lane JM, Jones SE, et al. Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes. Nat Commun. 2019;10(1):1–12. doi: 10.1038/s41467-019-11456-7.
    1. Xu X, Qu W, Bian M, Huang F, Fei J, Urade Y. Essential roles of GABA transporter-1 in controlling rapid eye movement sleep and in increased slow wave activity after sleep deprivation. PLoS ONE. 2013;8(10):e75823. doi: 10.1371/journal.pone.0075823.
    1. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain lulu. Science. 2014;342(6156):1–11. doi: 10.1126/science.1241224.Sleep.
    1. Kim Y-K, Nam KI, Song J. The glymphatic system in diabetes-induced dementia. Front Neurol. 2018;9(October):1–10. doi: 10.3389/fneur.2018.00867.
    1. Cam E, Gao B, Imbach L, Hodor A, Bassetti CL. Sleep deprivation before stroke is neuroprotective: a pre-ischemic conditioning related to sleep rebound. Exp Neurol. 2013;247:673–679. doi: 10.1016/j.expneurol.2013.03.003.
    1. Moldovan M, Constantinescu AO, Balseanu A, Oprescu N, Zagrean L, Popa-Wagner A. Sleep deprivation attenuates experimental stroke severity in rats. Exp Neurol. 2010;222(1):135–143. doi: 10.1016/j.expneurol.2009.12.023.
    1. Pace M, Adamantidis A, Facchin L, Bassetti C. Orexin/hypocretin role of REM sleep, melanin concentrating hormone and systems in the sleep deprivation pre-ischemia. PLoS ONE. 2017;12(1):1–22. doi: 10.1371/journal.pone.0168430.
    1. Jaskova K, Pavlovicova M, Jurkovicova D. Electrophysiological variability in the SH-SY5Y cellular line. Gen Physiol Biophys. 2014;31(4):375–382. doi: 10.4149/gpb.
    1. Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci. 2021;53(4):1136–1154. doi: 10.1111/ejn.15077.
    1. Beuckmann CT, Sinton CM, Williams SC, et al. Expression of a poly-glutamine-Ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci. 2004;24(18):4469–4477. doi: 10.1523/JNEUROSCI.5560-03.2004.
    1. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30(2):345–354. doi: 10.1016/S0896-6273(01)00293-8.
    1. Xiong X, White RE, Xu L, et al. Mitigation of murine focal cerebral ischemia by the hypocretin/ orexin system is associated with reduced inflammation. Stroke. 2013;44(3):764–770. doi: 10.1161/STROKEAHA.112.681700.Mitigation.
    1. Wei CJ, Li W, Chen JF. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim Biophys Acta. 2011;1808(5):1358–1379. doi: 10.1016/j.bbamem.2010.12.018.
    1. Zhou Y, Zeng X, Li G, et al. Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury. Br J Pharmacol. 2019;176(13):2250–2263. doi: 10.1111/bph.14673.
    1. Ledent C, Vaugeoist JM, Schiffmann SN, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor. Nature. 1997;388(6643):674–678. doi: 10.1038/41771.
    1. Hohoff C, Mullings EL, Heatherley SV, et al. Adenosine A2A receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res. 2010;44(14):930–937. doi: 10.1016/j.jpsychires.2010.02.006.
    1. Stanzione R, Di Angelantonio E, Evangelista A, et al. β2-adrenergic receptor gene polymorphisms and risk of ischemic stroke. Am J Hypertens. 2007;20(6):657–662. doi: 10.1016/j.amjhyper.2007.01.006.
    1. Schürks M, Kurth T, Ridker PM, Buring JE, Zee RYL. Association between polymorphisms in the β2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women. Thromb Haemost. 2009;101(2):351–358. doi: 10.1160/TH08-05-0284.
    1. Kumar A, Prasad M, Kumar P, Yadav AK, Pandit AK, Kathuria P. Association between beta adrenergic receptor polymorphism and ischemic stroke: a meta-analysis. J Stroke. 2015;17(2):138–143. doi: 10.5853/jos.2015.17.2.138.
    1. Vardeny O, Peppard PE, Finn LA, Faraco JH, Mignot E, Hla KM. β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study. J Am Soc Hypertens. 2011;5(2):114–122. doi: 10.1016/j.jash.2011.01.005.
    1. Proitsi P, Lupton MK, Reeves SJ, et al. Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging. 2012;33(4):791–803. doi: 10.1016/j.neurobiolaging.2010.06.011.
    1. Wang H, Noordam R, Cade BE, Schwander K, Thomas W. Multi-ancestry genome-wide gene-sleep interactions identify novel loci for blood pressure. Mol Psychiatry. 2021 doi: 10.1038/s41380-021-01087-0.
    1. Ohlsson T, Lindgren A, Engström G, Jern C, Melander O. A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity. J Hypertens. 2016;34(3):445–451. doi: 10.1097/HJH.0000000000000821.
    1. Noordam R, Bos MM, Wang H, et al. Multi-ancestry sleep-by-SNP interaction analysis in 126,926 individuals reveals lipid loci stratified by sleep duration. Nat Commun. 2019;10(1):1–13. doi: 10.1038/s41467-019-12958-0.
    1. Dashti HS, Follis JL, Smith CE, et al. Gene-environment interactions of circadian-related genes for cardiometabolic traits. Diabetes Care. 2015;38(8):1456–1466. doi: 10.2337/dc14-2709.
    1. Fallaize R, Carvalho-Wells AL, Tierney AC, et al. APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome. Sci Rep. 2017;7(1):1–10. doi: 10.1038/s41598-017-05802-2.
    1. Martínez-Martínez AB, Torres-Perez E, Devanney N, Del Moral R, Johnson LA, Arbones-Mainar JM. Beyond the CNS: the many peripheral roles of APOE. Neurobiol Dis. 2019;2020(138):104809. doi: 10.1016/j.nbd.2020.104809.
    1. Yesavage JA, Friedman L, Kraemer H, et al. Sleep/wake disruption in Alzheimer’s disease: APOE status and longitudinal course. J Geriatr Psychiatry Neurol. 2004;17(1):20–24. doi: 10.1177/0891988703261994.
    1. Pellegrino R, Mazzotti DR, Guindalini C, Santos-Silva R, Bittencourt LRA, Tufik S. Apolipoprotein E polymorphisms and sleep quality in obstructive sleep apnea syndrome. Clin Chim Acta. 2011;412(23–24):2223–2227. doi: 10.1016/j.cca.2011.08.007.
    1. Yang L, Ma L, Guo W, Fang Q, Lai X, Zhang X. Interaction of polymorphisms in APOA4-APOA5-ZPR1-BUD13 gene cluster and sleep duration on 5-year lipid changes in middle aged and older Chinese. Sleep. 2019;42(8):1–9. doi: 10.1093/sleep/zsz115.
    1. Hwang JY, Byun MS, Choe YM, et al. Moderating effect of APOE ∈4 on the relationship between sleep-wake cycle and brain β-amyloid. Neurology. 2018;90(13):e1167–e1173. doi: 10.1212/WNL.0000000000005193.
    1. Xue J, Zhou D, Poulsen O, et al. Intermittent hypoxia and hypercapnia accelerate atherosclerosis, partially via trimethylamine-oxide. Am J Respir Cell Mol Biol. 2017;57(5):581–588. doi: 10.1165/rcmb.2017-0086OC.
    1. Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res2. 2010;106(3):447–462. doi: 10.1161/CIRCRESAHA.109.208355.Circadian.
    1. Gamble KL, Berry R, Frank SJ, Young ME. Circadian clock control of endocrine factors. Nat Rev Endocrinol. 2014;10(8):466–475. doi: 10.1038/nrendo.2014.78.
    1. Guo L, Costanzo-Garvey DL, Smith DR, Neilsen BK, MacDonald RG, Lewis RE. Kinase Suppressor of Ras 2 (KSR2) expression in the brain regulates energy balance and glucose homeostasis. Mol Metab. 2017;6(2):194–205. doi: 10.1016/j.molmet.2016.12.004.
    1. Revelli JP, Smith D, Allen J, et al. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2. Obesity. 2011;19(5):1010–1018. doi: 10.1038/oby.2010.282.
    1. Pearce LR, Atanassova N, Banton MC, et al. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell. 2013;155(4):765. doi: 10.1016/j.cell.2013.09.058.
    1. Tekola-Ayele F, Doumatey AP, Shriner D, et al. Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome. Mol Genet Metab. 2015;116(4):305–313. doi: 10.1016/j.ymgme.2015.10.008.Genome-wide.
    1. Celis-Morales C, Lyall DM, Guo Y, et al. Sleep characteristics modify the association of genetic predisposition with obesity and anthropometric measurements in 119,679 UK Biobank participants. Am J Clin Nutr. 2017;105(4):980–990. doi: 10.3945/ajcn.116.147231.
    1. Dashti HS, Follis JL, Smith CE, et al. Habitual sleep duration is associated with BMI and macronutrient intake and may be modified by CLOCK genetic variants. Am J Clin Nutr. 2015;101(1):135–143. doi: 10.3945/ajcn.114.095026.
    1. Li G, Feng D, Wang Y, et al. Loss of Cardio-protective effects at the CDH13 locus due to gene-sleep interaction: the BCAMS Study. EBioMedicine. 2018;32:164–171. doi: 10.1016/j.ebiom.2018.05.033.
    1. Chung CM, Lin TH, Chen JW, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011;60(9):2417–2423. doi: 10.2337/db10-1321.
    1. Lin C, Tang X, Zhu Z, et al. The rhythmic expression of clock genes attenuated in human plaque-derived vascular smooth muscle cells. Lipids Health Dis. 2014;13(1):1–9. doi: 10.1186/1476-511X-13-14.
    1. Perisic L, Aldi S, Sun Y, et al. Gene expression signatures, pathways and networks in carotid atherosclerosis. J Intern Med. 2016;279(3):293–308. doi: 10.1111/joim.12448.
    1. Kaparianos A, Sampsonas F, Karkoulias K, Spiropoulos K. Obstructive sleep apnoea syndrome and genes. Neth J Med. 2006;64(8):280–289.
    1. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163(1):19–25. doi: 10.1164/ajrccm.163.1.2001008.
    1. Caples SM, Garcia-Touchard A, Somers VK. Sleep-disordered breathing and cardiovascular risk. Sleep. 2007;30(3):291–303. doi: 10.1093/sleep/30.3.291.
    1. Linz D, Woehrle H, Bitter T, et al. The importance of sleep-disordered breathing in cardiovascular disease. Clin Res Cardiol. 2015;104(9):705–718. doi: 10.1007/s00392-015-0859-7.
    1. Strausz S, Ruotsalainen S, Ollila HM, et al. Genetic analysis of obstructive sleep apnoea discovers a strong association with cardiometabolic health. Eur Respir J. 2021;57(5):2003091. doi: 10.1183/13993003.03091-2020.
    1. Parra O, Sánchez-Armengol A, Bonnin M, et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J. 2011;37(5):1128–1136. doi: 10.1183/09031936.00034410.
    1. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Stroke. 2019;50(12):E344–E418. doi: 10.1161/STR.0000000000000211.
    1. Prabhakar NR, Semenza GL. Responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012;92(3):967–1003. doi: 10.1152/physrev.00030.2011.ADAPTIVE.
    1. Minegishi S, Sagami I, Negi S, Kano K, Kitagishi H. Circadian clock disruption by selective removal of endogenous carbon monoxide. Sci Rep. 2018;8(1):1–12. doi: 10.1038/s41598-018-30425-6.
    1. Sun Q, Zeng C, Du L, Dong C. Mechanism of circadian regulation of the NRF2/ARE pathway in renal ischemia-reperfusion. Exp Ther Med. 2021;21(3):1–9. doi: 10.3892/etm.2021.9622.
    1. Zhou L, Ouyang R, Luo H, et al. Dysfunction of Nrf2-ARE signaling pathway: potential pathogenesis in the development of neurocognitive impairment in patients with moderate to severe obstructive sleep apnea-hypopnea syndrome. Oxid Med Cell Longev. 2018 doi: 10.1155/2018/3529709.
    1. Han Q, Yeung SC, Ip MSM, Mak JCW. Intermittent hypoxia-induced NF-κB and HO-1 regulation in human endothelial EA.hy926 Cells. Cell Biochem Biophys. 2013;66(3):431–441. doi: 10.1007/s12013-012-9491-6.
    1. Cao L, Zhang Z, Cai B, et al. Association of heme oxygenase-1 gene rs2071746 polymorphism with vascular outcomes in patients with atherosclerotic stroke. J Neurol Sci. 2014;344(1–2):154–157. doi: 10.1016/j.jns.2014.06.046.
    1. Oh J, Lee MS, Jeong JH, Lee M. Deoxycholic acid–conjugated polyethylenimine for delivery of heme oxygenase-1 gene in rat ischemic stroke model. J Pharm Sci. 2017;106(12):3524–3532. doi: 10.1016/j.xphs.2017.07.020.
    1. Hyun H, Won YW, Kim KM, Lee J, Lee M, Kim YH. Therapeutic effects of a reducible poly (oligo-d-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury. Biomaterials. 2010;31(34):9128–9134. doi: 10.1016/j.biomaterials.2010.08.038.
    1. Hyun H, Lee J, Hwang DW, et al. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials. 2011;32(1):306–315. doi: 10.1016/j.biomaterials.2010.08.116.
    1. Lee Y, Lee J, Kim M, Kim GY, Choi JS, Lee M. Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy. J Control Release. 2021;330(October):907–919. doi: 10.1016/j.jconrel.2020.10.064.
    1. Oh J, Kim SM, Lee EH, et al. Messenger RNA/polymeric carrier nanoparticles for delivery of heme oxygenase-1 gene in the post-ischemic brain. Biomater Sci. 2020;8(11):3063–3071. doi: 10.1039/d0bm00076k.
    1. Lavie L, Lotan R, Hochberg I, Herer P, Lavie P, Levy AP. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep. 2003;26(5):592–595. doi: 10.1093/sleep/26.5.592.
    1. Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2–2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2008;28(2):341–347. doi: 10.1161/ATVBAHA.107.153965.
    1. Staals J, Bons J, van Oostenbrugge R, et al. A SELDI-TOF-MS Study in Lacunar Stroke with Subsequent Haptoglobin Phenotyping. Curr Neurovasc Res. 2008;5(2):93–98. doi: 10.2174/156720208784310187.
    1. Staals J, Pieters B, Knottnerus I, et al. Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res. 2008;5(3):153–158. doi: 10.2174/156720208785425675.
    1. Merkler A, Sertić J, Bazina Martinović A, et al. Haptoglobin genotype 2–2 associated with atherosclerosis in patients with ischemic stroke. Gene. 2020 doi: 10.1016/j.gene.2020.144786.
    1. Ijäs P, Saksi J, Soinne L, et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis. 2013;230(2):228–234. doi: 10.1016/j.atherosclerosis.2013.07.008.
    1. Bale BF, Doneen AL, Vigerust DJ. Precision healthcare of type 2 diabetic patients through implementation of haptoglobin genotyping. Front Cardiovasc Med. 2018;5(October):1–8. doi: 10.3389/fcvm.2018.00141.
    1. Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D. Major Role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol. 2009;53(15):1309–1317. doi: 10.1016/j.jacc.2008.12.050.
    1. Abeysinghe HCS, Bokhari L, Dusting GJ, Roulston CL. Brain remodelling following endothelin-1 induced stroke in conscious rats. PLoS ONE. 2014;9(5):1–14. doi: 10.1371/journal.pone.0097007.
    1. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke. 1992;23(7):1014–1016. doi: 10.1161/01.STR.23.7.1014.
    1. Li J, Xu J, Liu Z, Zou Z, Jin M, Tao T. HIF-1α attenuates neuronal apoptosis by upregulating EPO expression following cerebral ischemia-reperfusion injury in a rat MCAO model. Int J Mol Med. 2020;45(4):1027–1036. doi: 10.3892/ijmm.2020.4480.
    1. Wakhloo D, Scharkowski F, Curto Y, et al. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11(1):1–12. doi: 10.1038/s41467-020-15041-1.
    1. Tani N, Ikeda T, Aoki Y, Shida A, Oritani S, Ishikawa T. Pathophysiological significance of clock genes BMAL1 and PER2 as erythropoietin-controlling factors in acute blood hemorrhage. Hum Cell. 2019 doi: 10.1007/s13577-019-00248-2.
    1. Mengozzi M, Cervellini I, Villa P, et al. Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proc Natl Acad Sci USA. 2012;109(24):9617–9622. doi: 10.1073/pnas.1200554109.
    1. Lam SY, Tipoe GL, Fung ML. Upregulation of erythropoietin and its receptor expression in the rat carotid body during chronic and intermittent hypoxia. Adv Exp Med Biol. 2009;648:207–214. doi: 10.1007/978-90-481-2259-2_24.
    1. Dayyat EA, Zhang SX, Wang Y, Cheng ZJ, Gozal D. Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apnea. BMC Neurosci. 2012;13(1):1. doi: 10.1186/1471-2202-13-77.
    1. Chen Q, Lin G, Huang J, et al. Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2. Aging. 2020;12(2):1899–1909. doi: 10.18632/aging.102729.
    1. Komnig D, Gertz K, Habib P, et al. Faim2 contributes to neuroprotection by erythropoietin in transient brain ischemia. J Neurochem. 2018;145(3):258–270. doi: 10.1111/jnc.14296.
    1. Kendzerska T, Kamra M, Murray BJ, Boulos MI. Incident cardiovascular events and death in individuals with restless legs syndrome or periodic limb movements in sleep: a systematic review. Sleep. 2017;40(3):1–14. doi: 10.1093/sleep/zsx013.
    1. Cholley-Roulleau M, Chenini S, Béziat S, Guiraud L, Jaussent I, Dauvilliers Y. Restless legs syndrome and cardiovascular diseases: a case-control study. PLoS ONE. 2017;12(4):1–13. doi: 10.1371/journal.pone.0176552.
    1. Ferini-Strambi L, Walters AS, Sica D. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease. J Neurol. 2014;261(6):1051–1068. doi: 10.1007/s00415-013-7065-1.
    1. Gao X, Ba DM, Bagai K, Liu G, Ma C, Walters AS. Treating restless legs syndrome was associated with low risk of cardiovascular disease: a cohort study with 3.4 years of follow-up. J Am Heart Assoc. 2021;10(4):1–15. doi: 10.1161/JAHA.120.018674.
    1. Winkelman JW, Blackwell T, Stone K, Ancoli-Israel S, Redline S. Associations of Incident cardiovascular events with restless legs syndrome and periodic leg movements of sleep in older men, for the outcomes of sleep disorders in older men study (MrOS Sleep Study) Sleep. 2017;40(4):11. doi: 10.1093/sleep/zsx023.
    1. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000–1006. doi: 10.1038/ng2099.
    1. Graff M, Scott RA, Justice AE, et al. Genome-wide physical activity interactions in adiposity—a meta-analysis of 200,452 adults. PLoS Genet. 2017;13(4):1–26. doi: 10.1371/journal.pgen.1006528.
    1. Bellei E, Bergamini S, Monari E, et al. Evaluation of potential cardiovascular risk protein biomarkers in high severity restless legs syndrome. J Neural Transm. 2019;126(10):1313–1320. doi: 10.1007/s00702-019-02051-7.
    1. Bellei E, Monari E, Ozben S, et al. Discovery of restless legs syndrome plasmatic biomarkers by proteomic analysis. Brain Behavior. 2018;8(10):1–9. doi: 10.1002/brb3.1062.
    1. Hu Z, Liu J, Song Z, Hou Q, Fan X, Hou D. Variants in the atherogenic ALOX5AP, THBD, and KNG1 genes potentiate the risk of ischemic stroke via a genetic main effect and epistatic interactions in a Chinese population. J Stroke Cerebrovasc Dis. 2015;24(9):2060–2068. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.036.
    1. Rohmann JL, de Haan HG, Algra A, Vossen CY, Rosendaal FR, Siegerink B. Genetic determinants of activity and antigen levels of contact system factors. J Thromb Haemost. 2019;17(1):157–168. doi: 10.1111/jth.14307.
    1. Sabater-Lleal M, Martinez-Perez A, Buil A, et al. A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI level and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2012;32(8):2008–2016. doi: 10.1161/ATVBAHA.112.248492.
    1. Mahta A, Yaghi S, Reznik ME, et al. Serum alpha-1 antitrypsin in acute ischemic stroke: a prospective pilot study. J Clin Neurosci. 2020;76:20–24. doi: 10.1016/j.jocn.2020.04.074.
    1. Wang T, Lu H, Li D, Huang W. Tgf-β1-mediated activation of serpine1 is involved in hemin-induced apoptotic and inflammatory injury in ht22 cells. Neuropsychiatr Dis Treat. 2021;17:423–433. doi: 10.2147/NDT.S293772.
    1. Malik R, Dau T, Gonik M, et al. Common coding variant in SERPINA1 increases the risk for large artery stroke. Proc Natl Acad Sci USA. 2017;114(14):3613–3618. doi: 10.1073/pnas.1616301114.
    1. Liu Q, Cui P, Zheng K, et al. SERPINA1 gene expression in whole blood links the rs6647 variant G allele to an increased risk of large artery atherosclerotic stroke. FASEB J. 2020;34(8):10107–10116. doi: 10.1096/fj.201903197R.
    1. Larsson SC, Markus HS. Genetic liability to insomnia and cardiovascular disease risk. Circulation. 2019;140(9):796–798. doi: 10.1161/CIRCULATIONAHA.119.041830.
    1. Parsa H, Imani A, Faghihi M, et al. Acute sleep deprivation preconditions the heart against ischemia/reperfusion injury: the role of central GABA-A receptors. Iran J Basic Med Sci. 2017;20:1232–1241. doi: 10.22038/IJBMS.2017.9539.
    1. Tao L, Wang L, Yang X, Jiang X, Hua F. Recombinant human glucagon-like peptide-1 protects against chronic intermittent hypoxia by improving myocardial energy metabolism and mitochondrial biogenesis. Mol Cell Endocrinol. 2018;2019(481):95–103. doi: 10.1016/j.mce.2018.11.015.
    1. Korkutata M, Saitoh T, Cherasse Y, et al. Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function. Neuropharmacology. 2018;2019(144):122–132. doi: 10.1016/j.neuropharm.2018.10.022.
    1. Li Y, Perry TA, Kindy MS, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci USA. 2009;106(4):1285–1290. doi: 10.1073/pnas.0806720106.
    1. Fang X, Tong KZ, Wang X, Ni HF. Two mixed-ligand coordination polymers: Crystal structures and protective effect on ischemic stroke by increasing glp1r expression. J Oleo Sci. 2020;69(7):743–750. doi: 10.5650/jos.ess20047.
    1. Shinozuka K, Staples M, Borlongan CV. Melatonin-based therapeutics for neuroprotection in stroke. Int J Mol Sci. 2013;14(5):8924–8947. doi: 10.3390/ijms14058924.
    1. Rhim T, Lee DY, Lee M. Hypoxia as a target for tissue specific gene therapy. J Control Release. 2013;172(2):484–494. doi: 10.1016/j.jconrel.2013.05.021.
    1. Jiménez-Ortega V, Barquilla PC, Pagano ES, Fernández-Mateos P, Esquifino AI, Cardinali DP. Melatonin supplementation decreases prolactin synthesis and release in rat adenohypophysis: correlation with anterior pituitary redox state and circadian clock mechanisms. Chronobiol Int. 2012;29(8):1021–1035. doi: 10.3109/07420528.2012.705936.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner